Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
This episode highlights how Watson's medical format can address real-world issues in dramatically interesting ways, with a ...
Discover effective strategies to minimize sickle cell pain crises and avoid hospitalizations. Leading hematologists share ...
On this week's episode of "Watson," Watson takes a major ethical risk when he decides to treat a sickle cell patient with an ...
ROCHESTER, N.Y. – Researchers at Golisano Children’s Hospital have received a multi-million-dollar grant to lead a ...